| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 50 |
| 1 | INFLIXIMAB | 43 |
| 2 | PREDNISONE | 27 |
| 3 | AZATHIOPRINE | 22 |
| 4 | AGALSIDASE BETA | 18 |
| 5 | ALGLUCOSIDASE ALFA | 18 |
| 6 | USTEKINUMAB | 17 |
| 7 | ERYTHROPOIETIN | 14 |
| 8 | ADALIMUMAB-AATY | 11 |
| 9 | ADALIMUMAB-ADAZ | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALGLUCOSIDASE ALFA | 18 | 0.0074 |
| 1 | INFLIXIMAB-DYYB | 10 | 0.0029 |
| 2 | LARONIDASE | 8 | 0.0019 |
| 3 | AGALSIDASE BETA | 18 | 0.0019 |
| 4 | ALLOPURINOL SODIUM | 1 | 0.0018 |
| 5 | VELAGLUCERASE ALFA | 3 | 0.0015 |
| 6 | DANTROLENE SODIUM | 1 | 0.0009 |
| 7 | IDURSULFASE | 3 | 0.0008 |
| 8 | ERYTHROPOIETIN | 14 | 0.0007 |
| 9 | CEFACLOR | 1 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 18 | 0.0053 |
| 1 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 18 | 0.0019 |
| 2 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 11 | 0.0008 |
| 3 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 4 | 0.0005 |
| 4 | Carnitine Analog [EPC] | 2 | 0.0005 |
| 5 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 6 | Purine Antimetabolite [EPC] | 22 | 0.0002 |
| 7 | Erythropoiesis-stimulating Agent [EPC] | 10 | 0.0002 |
| 8 | Interleukin-12 Antagonist [EPC] | 17 | 0.0002 |
| 9 | Interleukin-23 Antagonist [EPC] | 17 | 0.0002 |